Collin Culbertson to Fibrinolytic Agents
This is a "connection" page, showing publications Collin Culbertson has written about Fibrinolytic Agents.
Connection Strength
0.221
-
Aboul-Nour H, Siegler JE, Thompson SL, Glover PA, Daniel JA, Penckofer M, Smith MM, Yaghi S, Ro J, Chen L, D'Souza M, Khasiyev F, Kerrigan D, Sharma R, Aziz YN, Kirchhoffer K, Kam W, Melkumova E, Sloane KL, Lineback CM, Thottempudi N, Heaton S, Linares G, Singh E, Almallouhi E, Stretz C, Albert Fernandez CJ, Dumitrascu OM, Culbertson CJ, Elangovan C, Bowman A, Valhuerdi Porto C, Chahien D, Herpich F, Farooqui M, Kang J, de Havenon A, Nelson A, Shahrivari M, Stamm B, Khezri N, Lewis S, Sathya A, Leung LY, Eklund K, Rojas-Soto D, Nedelcu S, Al Kasab S, Van Coevering RJ, Thon J, Jillella DV, Nahab FB. Real-World Practice in Secondary Stroke Prevention Following Embolic Stroke of Undetermined Source: Secondary Analysis of the CASPR Registry. Neurol Clin Pract. 2026 Aug; 16(4):e200631.
Score: 0.221